(Q48379472)

11 February 2018

title

Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions (English)

1 reference

11 February 2018

0 references

van Horssen J

1

1 reference

11 February 2018

Vos CM

2

1 reference

11 February 2018

Admiraal L

3

1 reference

11 February 2018

van Haastert ES

4

1 reference

11 February 2018

Montagne L

5

1 reference

11 February 2018

van der Valk P

6

1 reference

11 February 2018

de Vries HE

7

1 reference

11 February 2018

publication date

1 December 2006

1 reference

11 February 2018

Neuropathology and Applied Neurobiology

published in

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

585-593

1 reference

11 February 2018

The worldwide prevalence of multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Tenascin-R and C in multiple sclerosis lesions: relevance to extracellular matrix remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinases: they're not just for matrix anymore!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Extracellular matrix remodelling: the role of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Regulation and Functional Effects of Monocyte Migration across Human Brain-Derived Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Identification of MMP-18, a putative novel human matrix metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Evaluation of some newer matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

Glial cell interactions with tenascin-C: adhesion and repulsion to different tenascin-C domains is cell type related

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00766.X

10.1111/J.1365-2990.2006.00766.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018